IGC Pharma (IGC) Amortization of Deferred Charges (2010 - 2022)
IGC Pharma (IGC) posted quarterly Amortization of Deferred Charges of $26000.0 for Q3 2022, little changed year-over-year from $26000.0 in Q3 2021, and down 7.14% quarter-over-quarter from $28000.0 in Q2 2022.
IGC Pharma (IGC) Amortization of Deferred Charges (2010 - 2022) Analysis & Trends
IGC Pharma (IGC) has reported Amortization of Deferred Charges for 11 consecutive years, with $26000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Amortization of Deferred Charges changed 0.0% year-over-year to $26000.0; the TTM figure through Sep 2022 stood at $116000.0 (up 107.14% YoY), while the FY2022 annual figure was $115000.0, up 422.73% from the prior year.
- Amortization of Deferred Charges declined to $26000.0 in Q3 2022 per IGC's latest filing, from $28000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $35000.0 in Q1 2022 and bottomed at -$115000.0 in Q1 2018.
- Historically, Amortization of Deferred Charges has averaged $7833.3 across 4 years, with a median of $23500.0 in 2020.
- Annual changes were most pronounced in 2018 — Amortization of Deferred Charges plunged 545.72% — and 2021, when it jumped 2600.0%.
- IGC Pharma's Amortization of Deferred Charges stood at $18000.0 in 2018, then sank by 94.44% to $1000.0 in 2020, then surged by 2600.0% to $27000.0 in 2021, then declined by 3.7% to $26000.0 in 2022.
- Business Quant data shows IGC's Amortization of Deferred Charges at $26000.0 in Q3 2022, $28000.0 in Q2 2022, and $35000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 26,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Jun 30, 2020 | 21,000.00 |